217314-44-8

Basic information

• Product Name: 2-fluoro-6-iodo-4-methylbenzenamine
• Synonyms: 2-fluoro-6-iodo-4-methylbenzenamine;2-Fluoro-6-iodo-4-methyl-phenylamin
• CAS NO: 217314-44-8
• Molecular Formula: C₇H₇FIN
• Molecular Weight: 251.0400532
• Mol File: 217314-44-8.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-fluoro-6-iodo-4-methylbenzenamine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-fluoro-6-iodo-4-methylbenzenamine(217314-44-8)
• EPA Substance Registry System: 2-fluoro-6-iodo-4-methylbenzenamine(217314-44-8)

Safety Data

• Hazardous Substances Data: 217314-44-8(Hazardous Substances Data)

Upstream product

• 452-80-2 2-fluoro-4-methylaniline 

Downstream Products

• 932373-57-4 1,1-dimethylethyl 4-({[(2-fluoro-6-iodo-4-methylphenyl)amino]-carbonyl}amino)-1-piperidinecarboxylate 
• 1403878-71-6 C₁₂H₁₄FNO 
• 1234779-89-5 4-[(1R,2S)-1-(4-chlorophenyl)-1-{7-fluoro-5-methyl-1-[(4-nitrophenyl)sulfonyl]-1H-indol-3-yl}pentan-2-yl]benzoic acid 
• 1403878-72-7 2-ethynyl-6-fluoro-4-methylaniline 
• 1234779-88-4 7-fluoro-5-methyl-1-[(4-nitrophenyl)sulfonyl]-1H-indole 
• 442910-91-0 7-fluoro-5-methyl-1H-indole 
• 1234779-91-9 C₃₇H₃₅ClFN₃O₇S 
• 1403878-69-2 ethyl N-({4-[(1R,2S)-1-(4-chlorophenyl)-1-{7-fluoro-5-methyl-1-[(4-nitrophenyl)sulfonyl]-1H-indol-3-yl}pentan-2-yl]phenyl}carbonyl)-β-alaninate 
• 1068160-31-5 1-fluoro-3-iodo-2-isocyanato-5-methylbenzene 
• 217314-39-1 1-(2-fluoro-6-methoxy-4-methylphenyl)-2,5-dimethyl-1H-pyrrole 
• 217314-46-0 2-fluoro-6-methoxy-4-methylaniline 
• 217314-38-0 1-(2-fluoro-6-iodo-4-methylphenyl)-2,5-dimethyl-1H-pyrrole 

Relevant articles and documents

INDOLES FOR USE IN INFLUENZA VIRUS INFECTION

The invention relates to compounds having the structure of formula (I) which can be used for the treatment of or against influenza infections.

1-(1-CYCLOBUTYL-4-PIPERIDINYL)-1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES WHICH HAVE ACTIVITY ON THE ML RECEPTOR AND THEIR USE IN MEDICINE

Compounds of formula I or a salt thereof are provided wherein R4, R5, R6, Q, L and R are as defined in the description. Uses of the compounds as medicaments and in the manufacture of medicaments for treating psychotic disorders and cognitive impairments are disclosed. The invention further discloses pharmaceutical compositions comprising the compounds.

COMPOUNDS WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE

Compounds which have activity at M1 receptor and their uses in medicine Compounds of formula (I) and salts and solvates are provided: wherein R4 is fluoro, R5 is selected from hydrogen, halogen, cyano, C1-6alkyl

1,1,1-TRIFLUORO-4-PHENYL-4-METHYL-2-(1H-PYRROLO

Compounds of Formula (IA), IB), IC), and (ID) wherein R1, R2, R3, R4, R5, and R6 are as respectively defined herein for Formula (IA), (IB), (IC), and (ID), or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.